Albert W. Brzeczko - Nov 20, 2023 Form 4 Insider Report for ACURA PHARMACEUTICALS, INC (ACUR)

Role
VP, Pharmaceutical Sciences - APT
Signature
/s/ Albert W. Brzeczko
Stock symbol
ACUR
Transactions as of
Nov 20, 2023
Transactions value $
$0
Form type
4
Date filed
11/20/2023, 12:07 PM
Previous filing
Jan 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACUR Common Stock Options Exercise +40K +8.97% 486K Nov 20, 2023 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACUR Restricted Stock Unit (2021 Plan) Options Exercise +40K 0 Nov 20, 2023 Common Stock 40K $0.01 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents exchange of restricted stock units.
F2 Par value of $.01 must be paid by Reporting Person upon exchange of Restricted Stock Units for stock.
F3 Not Applicable.
F4 40,000 Restricted Stock Units were granted on March 16, 2022 and were 100% vested on December 31, 2022

Remarks:

VP, Pharmaceutical Sciences - APT